Virbac: Jefferies still a buyer

(CercleFinance.com) - Jefferies maintains its buy rating on Virbac shares, along with its target price of 450 euros (share closed down 10% at 292 euros on Friday).


Following the strong sales performance in H1, Virbac's EBIT margin has benefitted from sales growth, despite the negative impact of inflationary headwinds, a rebound in commercial expenses and R&D spending to support future growth, the analyst said.

Jefferies notes that Virbac has maintained its FY22 guidance of 5%-10% revenue growth and an EBITA margin of around 15%.


Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.